A novel rat lipoxin A 4 receptor that is conserved in structure and function

Nan Chiang, Tomoko Takano, Makoto Arita, Shiro Watanabe, Charles N. Serhan

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

1. Lipoxin (LX) A 4 and aspirin-triggered-LX (ATL) are endogenous lipid-derived mediators that regulate leukocyte trafficking via specific LXA 4 receptors (ALX), and are involved in endogenous anti-inflammation and resolution. Both LXA 4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA 4 and ATL exhibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in rat tissues and its potential role in modulating leukocyte trafficking with LXA 4 and ATL. 2. In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 μg kg -1 each injection, significantly inhibited neutrophil infiltration (∼43%) and protein extravasation (∼42%) in a casein-induced peritonitis. 3. The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein-coupled receptor (GPCR). It gave ∼74 and ∼84% homology, respectively to the deduced amino-acid sequences of the human and mouse ALX. 4. Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where LXA 4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. 5. The rat orthologue of ALX gave specific radioligand binding with [ 3H]LXA 4 and [ 125-Tyr]-annexin 1-derived peptide with apparent K d values of 5 and 820 nM, respectively, that are at levels comparable to those of the human ALX. 6. Activation of rat ALX inhibited tumor necrosis factor alpha-mediated nuclear factor kappaB activity in a ligand-dependent manner utilizing a luciferase reporter gene system. 7. Together, these results are the first demonstration of a rat ALX that is conserved in both structure and function suggesting that ALX plays key roles in regulating effector immune responses from murine to human species.

Original languageEnglish
Pages (from-to)89-98
Number of pages10
JournalBritish Journal of Pharmacology
Volume139
Issue number1
DOIs
Publication statusPublished - 2003 May
Externally publishedYes

Fingerprint

Aspirin
Leukocytes
Lipoxins
Annexins
rat lipoxin A(4) receptor
Neutrophil Infiltration
Tissue Distribution
Ribonucleases
G-Protein-Coupled Receptors
Caseins
Peritonitis
Luciferases
Reporter Genes
Amino Acid Sequence
Tumor Necrosis Factor-alpha
Ligands
Inflammation
Kidney
Lipids
Lung

Keywords

  • ALX
  • Annexin 1
  • Aspirin-triggered lipoxin
  • GPCR
  • Inflammation
  • Lipoxin

ASJC Scopus subject areas

  • Pharmacology

Cite this

A novel rat lipoxin A 4 receptor that is conserved in structure and function. / Chiang, Nan; Takano, Tomoko; Arita, Makoto; Watanabe, Shiro; Serhan, Charles N.

In: British Journal of Pharmacology, Vol. 139, No. 1, 05.2003, p. 89-98.

Research output: Contribution to journalArticle

Chiang, Nan ; Takano, Tomoko ; Arita, Makoto ; Watanabe, Shiro ; Serhan, Charles N. / A novel rat lipoxin A 4 receptor that is conserved in structure and function. In: British Journal of Pharmacology. 2003 ; Vol. 139, No. 1. pp. 89-98.
@article{5cc547ed38374b29ae04624835972ffc,
title = "A novel rat lipoxin A 4 receptor that is conserved in structure and function",
abstract = "1. Lipoxin (LX) A 4 and aspirin-triggered-LX (ATL) are endogenous lipid-derived mediators that regulate leukocyte trafficking via specific LXA 4 receptors (ALX), and are involved in endogenous anti-inflammation and resolution. Both LXA 4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA 4 and ATL exhibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in rat tissues and its potential role in modulating leukocyte trafficking with LXA 4 and ATL. 2. In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 μg kg -1 each injection, significantly inhibited neutrophil infiltration (∼43{\%}) and protein extravasation (∼42{\%}) in a casein-induced peritonitis. 3. The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein-coupled receptor (GPCR). It gave ∼74 and ∼84{\%} homology, respectively to the deduced amino-acid sequences of the human and mouse ALX. 4. Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where LXA 4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. 5. The rat orthologue of ALX gave specific radioligand binding with [ 3H]LXA 4 and [ 125-Tyr]-annexin 1-derived peptide with apparent K d values of 5 and 820 nM, respectively, that are at levels comparable to those of the human ALX. 6. Activation of rat ALX inhibited tumor necrosis factor alpha-mediated nuclear factor kappaB activity in a ligand-dependent manner utilizing a luciferase reporter gene system. 7. Together, these results are the first demonstration of a rat ALX that is conserved in both structure and function suggesting that ALX plays key roles in regulating effector immune responses from murine to human species.",
keywords = "ALX, Annexin 1, Aspirin-triggered lipoxin, GPCR, Inflammation, Lipoxin",
author = "Nan Chiang and Tomoko Takano and Makoto Arita and Shiro Watanabe and Serhan, {Charles N.}",
year = "2003",
month = "5",
doi = "10.1038/sj.bjp.0705220",
language = "English",
volume = "139",
pages = "89--98",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - A novel rat lipoxin A 4 receptor that is conserved in structure and function

AU - Chiang, Nan

AU - Takano, Tomoko

AU - Arita, Makoto

AU - Watanabe, Shiro

AU - Serhan, Charles N.

PY - 2003/5

Y1 - 2003/5

N2 - 1. Lipoxin (LX) A 4 and aspirin-triggered-LX (ATL) are endogenous lipid-derived mediators that regulate leukocyte trafficking via specific LXA 4 receptors (ALX), and are involved in endogenous anti-inflammation and resolution. Both LXA 4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA 4 and ATL exhibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in rat tissues and its potential role in modulating leukocyte trafficking with LXA 4 and ATL. 2. In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 μg kg -1 each injection, significantly inhibited neutrophil infiltration (∼43%) and protein extravasation (∼42%) in a casein-induced peritonitis. 3. The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein-coupled receptor (GPCR). It gave ∼74 and ∼84% homology, respectively to the deduced amino-acid sequences of the human and mouse ALX. 4. Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where LXA 4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. 5. The rat orthologue of ALX gave specific radioligand binding with [ 3H]LXA 4 and [ 125-Tyr]-annexin 1-derived peptide with apparent K d values of 5 and 820 nM, respectively, that are at levels comparable to those of the human ALX. 6. Activation of rat ALX inhibited tumor necrosis factor alpha-mediated nuclear factor kappaB activity in a ligand-dependent manner utilizing a luciferase reporter gene system. 7. Together, these results are the first demonstration of a rat ALX that is conserved in both structure and function suggesting that ALX plays key roles in regulating effector immune responses from murine to human species.

AB - 1. Lipoxin (LX) A 4 and aspirin-triggered-LX (ATL) are endogenous lipid-derived mediators that regulate leukocyte trafficking via specific LXA 4 receptors (ALX), and are involved in endogenous anti-inflammation and resolution. Both LXA 4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA 4 and ATL exhibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in rat tissues and its potential role in modulating leukocyte trafficking with LXA 4 and ATL. 2. In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 μg kg -1 each injection, significantly inhibited neutrophil infiltration (∼43%) and protein extravasation (∼42%) in a casein-induced peritonitis. 3. The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein-coupled receptor (GPCR). It gave ∼74 and ∼84% homology, respectively to the deduced amino-acid sequences of the human and mouse ALX. 4. Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where LXA 4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. 5. The rat orthologue of ALX gave specific radioligand binding with [ 3H]LXA 4 and [ 125-Tyr]-annexin 1-derived peptide with apparent K d values of 5 and 820 nM, respectively, that are at levels comparable to those of the human ALX. 6. Activation of rat ALX inhibited tumor necrosis factor alpha-mediated nuclear factor kappaB activity in a ligand-dependent manner utilizing a luciferase reporter gene system. 7. Together, these results are the first demonstration of a rat ALX that is conserved in both structure and function suggesting that ALX plays key roles in regulating effector immune responses from murine to human species.

KW - ALX

KW - Annexin 1

KW - Aspirin-triggered lipoxin

KW - GPCR

KW - Inflammation

KW - Lipoxin

UR - http://www.scopus.com/inward/record.url?scp=0037716533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037716533&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705220

DO - 10.1038/sj.bjp.0705220

M3 - Article

VL - 139

SP - 89

EP - 98

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -